{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:40:43Z","timestamp":1787071243275,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Oral squamous cell carcinoma arising from oral submucous fibrosis (OSMF) is highly invasive with metastasis and high recurrence rate. WHO has categorized oral carcinoma as 6\n                      <jats:sup>th<\/jats:sup>\n                      most common cancer in male and 10\n                      <jats:sup>th<\/jats:sup>\n                      most common cancer in female. It is estimated that there are 7\u201313% chances of malignant transformation of OSMF, with 60% of cases fall under well-differentiated OSCC. CD147 also called as EMMPRIN (Basigin) is a transmembrane glycoprotein and found to be highly expressed by active cells like tumour cells and lymphocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>This study aims at evaluating the expression of EMMPRIN (CD147) in both OSMF and in oral squamous cell carcinoma through immunohistochemical technique, to use EMMPRIN as a marker for disease progression and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Method:<\/jats:title>\n                    <jats:p>In this study, we have taken 12 samples of OSMF and 12 samples of OSCC along with 5 normal tissue blocks as control. The tissue samples were all retrieved and taken from the Department of Oral Pathology and Microbiology which were reconfirmed by histopathological diagnosis. All the samples were poly-HRP (horse radish peroxidase) and PolyExcel Stunn substrate and chromogen. The staining was scored and analysed statistically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There was a significantly good expression in OSMF with 83.3% of cases, that is, 10 out of 12 show positive staining. Weak positive cases and moderately positive cases were 4 each, and strong positive cases were 2. This indicates that the staining increases as the stage advances. In OSCC, the number of cases showing positive staining was 5, which makes up to 41.7%. As the stage of OSCC increases, the expression of EMMPRIN (CD147) is expected to increase as it is a component important in both angiogenesis and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The 42% positive CD147 (EMMPRIN) expression in OSCC indicates that it may progress to the next stage of invasion and metastasis, whereas the 83% of positive cases of OSMF indicate that it is likely to transform into OSCC as early as possible. But further study with large sample size and proper distribution of samples in each stage of OSMF and OSCC can help in better analysis of the marker CD147 (EMMPRIN) as a predictor of prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_115_23","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:00:45Z","timestamp":1758880845000},"page":"441-451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Emmprin (CD147) expression in oral submucous fibrosis and in oral squamous cell carcinoma\u2014A potential predictor"],"prefix":"10.4103","volume":"29","author":[{"given":"Rajshri","family":"Raveendran","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillo Facial Pathology, Madha Dental College and Hospital, Kundrathur, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Gopalakrishan","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillo Facial Pathology, Madha Dental College and Hospital, Kundrathur, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghini","family":"Ramamoorthi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillo Facial Pathology, Madha Dental College and Hospital, Kundrathur, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Muniapillai","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillo Facial Pathology, Madha Dental College and Hospital, Kundrathur, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"R1-20250926","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/jomfp.JOMFP_16_18","article-title":"Clinicopathological analysis of oral squamous cell carcinoma among the younger age group in coastal Karnataka, India:A retrospective study","volume":"22","author":"Abdulla","year":"2018","journal-title":"J Oral Maxillofac Pathol"},{"key":"R2-20250926","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.7314\/APJCP.2014.15.16.6755","article-title":"Demographic risk factors, affected anatomical sites and clinicopathological profile for oral squamous cell carcinoma in a north Indian population","volume":"15","author":"Krishna","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4137\/CMO.S12950","article-title":"Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions:A systematic review","volume":"7","author":"Abdulmajeed","year":"2013","journal-title":"Clin Med Insights Oncol"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/njms.NJMS_32_17","article-title":"Oral submucous fibrosis:Newer proposed classification with critical updates in pathogenesis and management strategies","volume":"8","author":"Passi","year":"2017","journal-title":"Natl J Maxillofac Surg"},{"key":"R5-20250926","first-page":"126","article-title":"Epidemiology of oral submucous fibrosis:A review","volume":"3","author":"Das","year":"2017","journal-title":"Int J Oral Health Med Res"},{"key":"R6-20250926","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0970-9290.29877","article-title":"Prevalence of oral lesions in relation to habits:Cross-sectional study in South India","volume":"17","author":"Saraswathi","year":"2006","journal-title":"Indian J Dent Res"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.oooo.2015.12.018","article-title":"Oral submucous fibrosis:Review on mechanisms of malignant transformation","volume":"122","author":"Ekanayaka","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R8-20250926","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/ams.ams_280_18","article-title":"Carcinoma arising in the background of oral submucous fibrosis","volume":"9","author":"Rangaswamy","year":"2019","journal-title":"Ann Maxillofac Surg"},{"key":"R9-20250926","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jop.12582","article-title":"Oral submucous fibrosis:An update on pathophysiology of malignant transformation","volume":"46","author":"Arakeri","year":"2017","journal-title":"J Oral Pathol Med"},{"key":"R10-20250926","doi-asserted-by":"crossref","first-page":"17411","DOI":"10.3390\/ijms151017411","article-title":"The biological function and clinical utilization of CD147 in human diseases:A review of the current scientific literature","volume":"15","author":"Xiong","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R11-20250926","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12931-016-0334-7","article-title":"Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts","volume":"17","author":"Hasaneen","year":"2016","journal-title":"Respir Res"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40463-020-0399-7","article-title":"Oral submucous fibrosis:A contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management","volume":"49","author":"Rao","year":"2020","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R13-20250926","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijom.2010.12.003","article-title":"Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma","volume":"40","author":"Oliveira","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R14-20250926","doi-asserted-by":"crossref","first-page":"905680","DOI":"10.1155\/2014\/905680","article-title":"EMMPRIN expression in oral squamous cell carcinomas:Correlation with tumor proliferation and patient survival","volume":"2014","author":"Monteiro","year":"2014","journal-title":"Biomed Res Int"},{"key":"R15-20250926","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajoms.2017.06.014","article-title":"Immunohistochemical expression of EMMPRIN (CD147) in oral squamous cell carcinoma","volume":"30","author":"Sahaf","year":"2018","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"R16-20250926","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3329\/bmjk.v47i1-2.22554","article-title":"Clinical profile of oral squamous cell carcinoma patients attending a tertiary care hospital","volume":"47","author":"Rahman","year":"2014","journal-title":"Bangladesh Medical Journal Khulna"},{"key":"R17-20250926","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.4317\/medoral.18043","article-title":"Prevalence trends of oral squamous cell carcinoma.Mexico City's General Hospital experience","volume":"18","author":"Hern\u00e1ndez-Guerrero","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R18-20250926","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jop.13088","article-title":"CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and ?-catenin","volume":"49","author":"Min","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"R19-20250926","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<347::AID-IJC9>3.0.CO;2-#","article-title":"Expression of emmprin by oral squamous cell carcinoma","volume":"85","author":"Bordador","year":"2000","journal-title":"Int J Cancer"},{"key":"R20-20250926","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexmp.2007.08.014","article-title":"CD147 immunoglobulin superfamily receptor function and role in pathology","volume":"83","author":"Iacono","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"R21-20250926","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00432-011-1142-6","article-title":"Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma","volume":"138","author":"Piao","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"R22-20250926","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajpath.2010.10.009","article-title":"Basigin\/CD147 promotes renal fibrosis after unilateral ureteral obstruction","volume":"178","author":"Kato","year":"2011","journal-title":"Am J Pathol"},{"key":"R23-20250926","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1042\/CS20140823","article-title":"CD147 promotes liver fibrosis progression via VEGF-A\/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells","volume":"129","author":"Yan","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"R24-20250926","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jop.12836","article-title":"Oral submucous fibrosis:A clinicopathological study of 674 cases in China","volume":"48","author":"Cai","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"R25-20250926","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0970-4388.26022","article-title":"Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India","volume":"24","author":"Ahmad","year":"2006","journal-title":"J Indian Soc Pedod Prev Dent"},{"key":"R26-20250926","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/odi.12845","article-title":"Experimental study on TGF-?1-mediated CD147 expression in oral submucous fibrosis","volume":"24","author":"Wang","year":"2018","journal-title":"Oral Dis"},{"key":"R27-20250926","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/1523-1747.ep12348959","article-title":"Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer","volume":"106","author":"DeCastro","year":"1996","journal-title":"J Invest Dermatol"},{"key":"R28-20250926","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3353\/omp.15.21","article-title":"Relationship of fibrosis and the expression of TGF-?1, MMP-1, and TIMP-1 with epithelial dysplasia in oral submucous fibrosis","volume":"15","author":"Illeperuma","year":"2010","journal-title":"Oral Medicine and Pathology"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_115_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:43:34Z","timestamp":1787067814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_115_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_115_23","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2023-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}